Literature DB >> 26446322

Osteoporosis in Saudi Arabia. Are we doing enough?

Basmah K Alwahhabi1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26446322      PMCID: PMC4621717          DOI: 10.15537/smj.2015.10.11939

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


× No keyword cloud information.
No disease has attracted attention in the last 2 decades all over the world, such as osteoporosis. Being a silent disease with high prevalence among older population, the battle is difficult. The situation is not different in the Kingdom of Saudi Arabia (KSA). An epidemiological analysis showed that 34% of healthy Saudi women, and 30.7% of men, 50-79 years of age are osteoporotic.1 With a reported increased life expectancy in KSA increasing from 45-67 years in 1960 to 75.7 years in 2013,2 the prevalence of osteoporosis is expected to increase even further. Lifestyle factors play a significant role in the high prevalence of this disease, with low calcium intake, lack of physical activity, and a higher prevalence of vitamin D deficiency, being among the main culprits. In KSA, there is approximately 8,768 femoral fractures each year costing billions, and being an endemic area for vitamin D deficiency, bone health is becoming a serious concern in the kingdom. Correct interpretation of bone mineral density measurements by dual energy x-ray absorptiometry (DEXA) requires a population-specific reference range. Currently, we are using Western software in our DEXA machines. Does this affect the accuracy of diagnosing patients?

Where are we from improving osteoporosis awareness among physicians?

After 12 years of practicing hospital based osteoporosis practice, I still find under and over- diagnosis referrals to be common. When I see an elderly on high steroid dose for many years referred only after suffering multiple fractures or a 40-years old woman without any risk factor who is referred as a case of osteoporosis because her bone density is low, I realize how silent the disease can be for both patients and doctors, and that we are miles away from achieving optimal care. It is worth mentioning that these are not uncommon situations in our practice. The notes cited above are not meant to downgrade other specialties; rather, it emphasizes the point that the quality of care needs urgent intervention by multidisciplinary health care teams and professional organizations to improve awareness.

What can we do to improve osteoporosis care?

The Saudi Osteoporosis Society adopted the mission of providing health care providers with evidence based learning in the field of osteoporosis through organizing annual courses and conferences. A mandatory vitamin D fortified milk products (such as Laban, a common drink in KSA) policy is needed. Establishing such policy requires collaboration of MOH with SOS and the major dairy products companies. The clinical decision to treat or not treat patients with osteopenia mandates using the Fracture Risk Assessment Tool (FRAX) developed by the World Health Organization.3 The FRAX calculator combines a set of clinical risk factors with country-specific incidence rates to determine the ten-year absolute risk of major osteoporotic fracture. However, regional or country-specific databases from KSA are not available. To get hold of that, a steering group must be set up to drive the establishment of a National Hip Fracture Registry. The group should be supported by funds and dedicated members to roll up their sleeves, and undertake the groundwork needed to make it happen. A growing body of published literature suggests that provision of secondary preventative care post-hip fracture (osteoporosis assessment/treatment and falls prevention strategies) is not routinely delivered.4 The time has come to implement the internationally well-established Fracture Liaison Services (FLS). This is a coordinator-based, secondary fracture prevention service designed to close the care gap for fracture patients, 80% of whom are currently never offered screening and/or treatment for osteoporosis. It enhances the communication between health care providers (endocrine, orthopedics, trained nurse) by providing a care pathway for the treatment of fragility fracture patients.5 Osteoporosis will continue to be unabated unless concerned institutions combine their effort, and start applying national positive actions to improve osteoporosis awareness, screening, prevention, and treatment.
  2 in total

1.  Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough?

Authors:  Hosam K Kamel
Journal:  J Clin Rheumatol       Date:  2005-04       Impact factor: 3.517

Review 2.  An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population.

Authors:  Mir Sadat-Ali; Ibrahim M Al-Habdan; Haifa A Al-Turki; Mohammed Quamar Azam
Journal:  Ann Saudi Med       Date:  2012 Nov-Dec       Impact factor: 1.526

  2 in total
  7 in total

1.  Lifestyle factors influencing bone health in young adult women in Saudi Arabia.

Authors:  Lina F Hammad; Nada Benajiba
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

2.  Osteoporosis in Saudi Arabia.

Authors:  Ali S Jawad
Journal:  Saudi Med J       Date:  2016-04       Impact factor: 1.484

3.  The Prevalence and Risk Factors of Osteoporosis among a Saudi Female Diabetic Population.

Authors:  Ibrahim Abdulrazag Al-Homood; Iman Sheshah; Abdel Gaffar A Mohammed; Gasim I Gasim
Journal:  Open Access Maced J Med Sci       Date:  2017-04-08

4.  Assessing health beliefs about osteoporosis among women attending primary health care centres in Qatar.

Authors:  Hissa Al-Muraikhi; Mohamad A Chehab; Hana Said; Nagah Selim
Journal:  J Taibah Univ Med Sci       Date:  2017-01-05

5.  Prevalence and risk factors for osteoporotic fracture among adults with comorbidities in Al-Ahsaa, Saudi Arabia.

Authors:  Naif M Al Hamam; Ghusoon F Al-Moaibed; Emad H Alfayez; Eman H Alfayez; Mohammed Saud Al-Mubaddil; Narjes Ali Alramadhan
Journal:  J Family Med Prim Care       Date:  2020-02-28

6.  Vitamin D Metabolites and Sex Steroid Indices in Postmenopausal Women with and without Low Bone Mass.

Authors:  Nasser M Al-Daghri; Sobhy M Yakout; Mohammed G A Ansari; Syed D Hussain; Kaiser A Wani; Shaun Sabico
Journal:  Metabolites       Date:  2021-02-01

7.  Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide.

Authors:  Abdul Aziz Elsalmawy; Nadia S Al-Ali; Yasser Yaghi; Hussein Assaggaf; Ghassan Maalouf; Mir Sadat-Ali; Essam Zaher; Said Saghieh; Ahmed Mahmoud; Mohamed Taher
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.